CurveBeam AI (ASX:CVB) Beneish M-Score: -2.79 (As of Jun. 24, 2026)


What is CurveBeam AI Beneish M-Score?

CurveBeam AI ASX:CVB -6.67% Beneish M-Score is -2.79 as of Jun. 24, 2026. The stock has 5 warning signs investors should review. Among 765 Medical Devices & Instruments companies, CurveBeam AI ranks better than 67.32% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.79 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for CurveBeam AI's Beneish M-Score or its related term are showing as below:

ASX:CVB' s Beneish M-Score Range Over the Past 10 Years
Min: -2.79   Med: -2.71   Max: -2.63
Current: -2.79

During the past 5 years, the highest Beneish M-Score of CurveBeam AI was -2.63. The lowest was -2.79. And the median was -2.71.


CurveBeam AI Beneish M-Score Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Beneish M-Score Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Beneish M-Score
0.00 0.00 0.00 -2.63 -2.79

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only 0.00 -2.63 0.00 -2.79 0.00

ASX:CVB vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, CurveBeam AI's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CurveBeam AI Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's Beneish M-Score falls into.



CurveBeam AI Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of CurveBeam AI for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.4342+0.528 * 1.0262+0.404 * 1.0273+0.892 * 1.8534+0.115 * 1.2395
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.5012+4.679 * -0.14025-0.327 * 1.1073
=-2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Total Receivables was A$3.14 Mil.
Revenue was A$12.10 Mil.
Gross Profit was A$5.43 Mil.
Total Current Assets was A$20.26 Mil.
Total Assets was A$60.98 Mil.
Property, Plant and Equipment(Net PPE) was A$2.64 Mil.
Depreciation, Depletion and Amortization(DDA) was A$2.98 Mil.
Selling, General, & Admin. Expense(SGA) was A$16.74 Mil.
Total Current Liabilities was A$8.21 Mil.
Long-Term Debt & Capital Lease Obligation was A$16.02 Mil.
Net Income was A$-16.84 Mil.
Gross Profit was A$2.88 Mil.
Cash Flow from Operations was A$-11.17 Mil.
Total Receivables was A$3.90 Mil.
Revenue was A$6.53 Mil.
Gross Profit was A$3.01 Mil.
Total Current Assets was A$23.36 Mil.
Total Assets was A$63.33 Mil.
Property, Plant and Equipment(Net PPE) was A$1.47 Mil.
Depreciation, Depletion and Amortization(DDA) was A$2.83 Mil.
Selling, General, & Admin. Expense(SGA) was A$18.02 Mil.
Total Current Liabilities was A$8.17 Mil.
Long-Term Debt & Capital Lease Obligation was A$14.56 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3.142 / 12.097) / (3.904 / 6.527)
=0.259734 / 0.598131
=0.4342

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3.007 / 6.527) / (5.431 / 12.097)
=0.460702 / 0.448954
=1.0262

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (20.264 + 2.641) / 60.984) / (1 - (23.362 + 1.474) / 63.329)
=0.62441 / 0.607826
=1.0273

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=12.097 / 6.527
=1.8534

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.829 / (2.829 + 1.474)) / (2.983 / (2.983 + 2.641))
=0.657448 / 0.530405
=1.2395

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(16.738 / 12.097) / (18.018 / 6.527)
=1.383649 / 2.760533
=0.5012

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((16.018 + 8.212) / 60.984) / ((14.558 + 8.166) / 63.329)
=0.397317 / 0.358825
=1.1073

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-16.843 - 2.88 - -11.17) / 60.984
=-0.14025

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

CurveBeam AI has a M-score of -2.79 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.79 mean?
CurveBeam AI (ASX:CVB) has a Beneish M-Score of -2.79 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on CurveBeam AI and its competitors. According to the industry distribution chart, CurveBeam AI ranks #250 out of 765 companies in the Medical Devices & Instruments industry, placing it in the top 32.7%.
Is CurveBeam AI's Beneish M-Score too high?
CurveBeam AI's current Beneish M-Score is -2.79. Based on the distribution chart, CurveBeam AI ranks #250 out of 765 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does CurveBeam AI's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CurveBeam AI ranks #250 out of 765 companies for Beneish M-Score. This puts CurveBeam AI in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on CurveBeam AI and its competitors. CurveBeam AI's current Beneish M-Score is -2.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current Beneish M-Score of -2.79. The current Beneish M-Score is -2.79. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Beneish M-Score is -2.79 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.